Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study

OBJECTIVES: Appendiceal cancer is a rare malignancy, occurring in roughly 1.2 per 100,000 per year. Low grade appendiceal neoplasams (LAMN) in particular can lead to pseudomyxoma peritonei (PMP), and respond poorly to systemic chemotherapy. Standard treatment includes cytoreduction surgery (CRS) wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayler, Raymond, Lockhart, Kathleen, Barat, Shoma, Cheng, Ernest, Mui, Jasmine, Shamavonian, Raphael, Ahmadi, Nima, Alzahrani, Nayef, Liauw, Winston, Morris, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067551/
https://www.ncbi.nlm.nih.gov/pubmed/37020474
http://dx.doi.org/10.1515/pp-2022-0205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067551/
https://www.ncbi.nlm.nih.gov/pubmed/37020474
http://dx.doi.org/10.1515/pp-2022-0205

Ejemplares similares